Risk of prolonged postoperative opioid use after elective shoulder replacement: a nationwide cohort study of 5,660 patients from the Danish Shoulder Arthroplasty Registry
DOI:
https://doi.org/10.2340/17453674.2024.41090Keywords:
Arthroplasty, Epidemiology, Opioids, ShoulderAbstract
Background and purpose: Several studies from the United States report an increased risk of prolonged opioid use after shoulder replacement. We aimed to determine the incidence and risk factors of prolonged opioid use after elective shoulder replacement in a nationwide Danish population.
Methods: All primary elective shoulder arthroplasties reported to the Danish Shoulder Arthroplasty Registry (DSR) from 2004 to 2020 were screened for eligibility. Data on potential risk factors was retrieved from the DSR and the National Danish Patient Registry while data on medication was retrieved from the Danish National Health Service Prescription Database. Prolonged opioid use was defined as 1 or more dispensed prescriptions on and 90 days after date of surgery (Q1) and subsequently 1 or more dispensed prescriptions 91–180 days after surgery (Q2). Preoperative opioid use was defined as 1 or more dispensed prescriptions 90 days before surgery. Logistic regression models were used to estimate risk factors for prolonged opioid use.
Results: We included 5,660 patients. Postoperatively 1,584 (28%) patients were dispensed 1 or more prescriptions in Q1 and Q2 and were classified as prolonged opioid users. Among the 2,037 preoperative opioid users and the 3,623 non-opioid users, 1,201 (59%) and 383 (11%) respectively were classified as prolonged users. Preoperative opioid use, female sex, alcohol abuse, previous surgery, high Charlson Comorbidity index, and preoperative use of either antidepressants, antipsychotics, or benzodiazepines were associated with increased risk of prolonged opioid use.
Conclusion: The incidence of prolonged opioid use was 28%. Preoperative use of opioids was the strongest risk factor for prolonged opioid use, but several other risk factors were identified for prolonged opioid use.
Downloads
References
Khazi Z M, Lu Y, Patel B H, Cancienne J M, Werner B, Forsythe B. Risk factors for opioid use after total shoulder arthroplasty. J Shoulder Elbow Surg 2020; 29(2): 235-43. doi: 10.1016/j.jse.2019.06.020.
Simoni A H, Nikolajsen L, Olesen A E, Christiansen C F, Pedersen A B. Opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2015. Eur J Pain 2019; 23(7): ejp.1392. doi: 10.1002/ejp.1392.
Leroux T S, Saltzman B M, Sumner S A, Maldonado-Rodriguez N, Agarwalla A, Ravi B, et al. Elective shoulder surgery in the opioid naïve: rates of and risk factors for long-term postoperative opioid use. Am J Sports Med 2019; 47(5): 1051-6. doi: 10.1177/0363546519837516.
Clarke H, Soneji N, Ko D T, Yun L, Wijeysundera D N. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014; 348(3): g1251. doi: 10.1136/bmj.g1251.
Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, et al. Use of and barriers to access to opioid analgesics: s worldwide, regional, and national study. Lancet 2016; 387(10028): 1644-56. doi: 10.1016/S0140-6736(16)00161-6.
Okie S. A Flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363(21): 1981-5. doi: 10.1056/nejmp1011512.
Mattson C L, O’Donnell J, Kariisa M, Seth P, Scholl L, Gladden R M. Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016–June 2017. MMWR Morb Mortal Wkly Rep 2018; 67(34): 945-951. doi: 10.15585/MMWR.MM6734A2.
Neuman M D, Bateman B T, Wunsch H. Inappropriate opioid prescription after surgery. Lancet 2019; 393(10180): 1547-57. doi: 10.1016/S0140-6736(19)30428-3.
Volkow N D, McLellan T A, Cotto J H, Karithanom M, Weiss S R B. Characteristics of opioid prescriptions in 2009. JAMA 2011; 305(13): 1299-301. doi: 10.1001/JAMA.2011.401.
Jiang X, Orton M, Feng R, Hossain E, Malhotra N R, Zager E L et al. Chronic opioid usage in surgical patients in a large academic center. Ann Surg 2017; 265(4): 722-7. doi: 10.1097/SLA.0000000000001780.
Vos T, Abajobir A A, Abate K H, Abbafati C, Abbas K M, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390(10100): 1211-59. doi: 10.1016/S0140-6736(17)32154-2.
Rao A G, Chan P H, Prentice H A, Paxton E W, Navarro R A, Dillon M T, et al. Risk factors for postoperative opioid use after elective shoulder arthroplasty. J Shoulder Elb Surg 2018; 27(11): 1960-8. doi: 10.1016/j.jse.2018.04.018.
Berglund D D, Rosas S, Kurowicki J, Horn B, Mijic D, Levy J C. Preoperative opioid use among patients undergoing shoulder arthroplasty predicts prolonged postoperative opioid use. J Am Acad Orthop Surg 2018; 27(15): e691-e695. doi: 10.5435/JAAOS-D-18-00008.
McDonald D C, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain 2012; 13(10): 988. doi: 10.1016/J.JPAIN.2012.07.007.
Rasmussen J V, Jakobsen J, Brorson S, Olsen B S. The Danish Shoulder Arthroplasty Registry: clinical outcome and short-term survival of 2,137 primary shoulder replacements. Acta Orthop 2012; 83(2): 171-3. doi: 10.3109/17453674.2012.665327.
Rasmussen J V, Amundsen A, Sørensen A K B, Klausen T W, Jakobsen J, Jensen S L, et al. Increased use of total shoulder arthroplasty for osteoarthritis and improved patient-reported outcome in Denmark, 2006–2015: a nationwide cohort study from the Danish Shoulder Arthroplasty Registry. Acta Orthop 2019; 90(5): 489-94. doi: 10.1080/17453674.2019.1633759.
Rasmussen J V, El-Galaly A, Thillemann T M, Jensen S L. High completeness and accurate reporting of key variables make data from the Danish Shoulder Arthroplasty Registry a valuable source of information. Clin Epidemiol 2021; 13: 141-8. doi: 10.2147/CLEP.S291972.
Pottegård A, Schmidt S A J, Wallach-Kildemoes H, Sørensen H T, Hallas J, Schmidt M. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 2017; 46(3): 798-798f. doi: 10.1093/IJE/DYW213.
Schmidt M, Schmidt S A J, Sandegaard J L, Ehrenstein V, Pedersen L, Sørensen H T. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449. doi: 10.2147/CLEP.S91125.
Centers for Disease Control and Prevention. Quality improvement and care coordination: implementing the CDC Guideline for Prescribing Opioids for Chronic Pain. Atlanta, GA: Natl Cent Inj Prev Control Div Unintentional Inj Prev. Published online 2018. Available from: https://stacks.cdc.gov/view/cdc/59082.
Schug S A, Lavand’Homme P, Barke A, Korwisi B, Rief W, Treede R D. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain 2019; 160(1): 45-52. doi: 10.1097/J.PAIN.0000000000001413.
Clarke H, Soneji N, Ko D T, Yun L, Wijeysundera D N. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014; 348. doi: 10.1136/bmj.g1251.
Jones C A, Throckmorton T W, Murphy J, Eason R R, Joyce M, Bernholt D L, et al. Opioid-sparing pain management protocol after shoulder arthroplasty results in less opioid consumption and higher satisfaction: a prospective, randomized controlled trial. J Shoulder Elb Surg 2022; 31(10): 2057-65. doi: 10.1016/j.jse.2022.05.029.
Jolissaint J E, Scarola G T, Odum S M, Leas D, Hamid N, Chapman T M, et al. Opioid-free shoulder arthroplasty is safe, effective, and predictable compared with a traditional perioperative opiate regimen: a randomized controlled trial of a new clinical care pathway. J Shoulder Elb Surg 2022; 31(7): 1499-509. doi: 10.1016/j.jse.2021.12.015.
Reid D B C, Shah K N, Shapiro B H, Ruddell J H, Akelman E, Daniels A H. Mandatory prescription limits and opioid utilization following orthopaedic surgery. J Bone Joint Surg 2019; 101(10): e43. doi: 10.2106/JBJS.18.00943.
Nguyen L C L, Sing D C, Bozic K J. Preoperative reduction of opioid use before total joint arthroplasty. J Arthroplasty 2016; 31(9): 282-7. doi: 10.1016/j.arth.2016.01.068.
Uhrbrand P, Rasmussen M M, Haroutounian S, Nikolajsen L. Shared decision-making approach to taper postoperative opioids in spine surgery patients with preoperative opioid use: a randomized controlled trial. Pain 2022; 163(5): E634-E641. doi: 10.1097/J.PAIN.0000000000002456
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Alexander Scheller Madrid, Jeppe Vejlgaard Rasmussen
This work is licensed under a Creative Commons Attribution 4.0 International License.
